Literature DB >> 26283009

Is There Another Bite of the Cherry? The Case for Radical Local Therapy for Oligometastatic Disease in Prostate Cancer.

Vincent Khoo1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26283009     DOI: 10.1016/j.eururo.2015.07.073

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  6 in total

Review 1.  Oligometastatic prostate cancer: definitions, clinical outcomes, and treatment considerations.

Authors:  Jeffrey J Tosoian; Michael A Gorin; Ashley E Ross; Kenneth J Pienta; Phuoc T Tran; Edward M Schaeffer
Journal:  Nat Rev Urol       Date:  2016-10-11       Impact factor: 14.432

Review 2.  Oligometastatic Prostate Cancer.

Authors:  Daniel J Stevens; Prasanna Sooriakumaran
Journal:  Curr Treat Options Oncol       Date:  2016-12

Review 3.  Harnessing the potential of multimodal radiotherapy in prostate cancer.

Authors:  Yiannis Philippou; Hanna Sjoberg; Alastair D Lamb; Philip Camilleri; Richard J Bryant
Journal:  Nat Rev Urol       Date:  2020-05-01       Impact factor: 14.432

4.  Locoregional control and survival after lymph node SBRT in oligometastatic disease.

Authors:  Mauro Loi; Michael Frelinghuysen; Natalie Desiree Klass; Esther Oomen-De Hoop; Patrick Vincent Granton; Joachim Aerts; Cornelis Verhoef; Joost Nuyttens
Journal:  Clin Exp Metastasis       Date:  2018-07-11       Impact factor: 5.150

5.  The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer.

Authors:  Ciro Franzese; Paolo Andrea Zucali; Lucia Di Brina; Giuseppe D'Agostino; Pierina Navarria; Davide Franceschini; Armando Santoro; Marta Scorsetti
Journal:  Cancer Med       Date:  2018-08-02       Impact factor: 4.452

6.  [18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer.

Authors:  Francesco Pasqualetti; Marco Panichi; Martina Sollini; Aldo Sainato; Luca Galli; Riccardo Morganti; Serena Chiacchio; Andrea Marciano; Roberta Zanca; Lorenzo Mannelli; Gabriele Coraggio; Andrea Sbrana; Paola Cocuzza; Sabrina Montrone; Davide Baldaccini; Alessandra Gonnelli; Alessandro Molinari; Martina Cantarella; Valentina Mazzotti; Sergio Ricci; Fabiola Paiar; Paola Anna Erba
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-16       Impact factor: 9.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.